Submit Article
Home » The modular facility manufacturing market is projected to grow at an annualized rate of ~8.8%, till 2030
Health & Fitness

The modular facility manufacturing market is projected to grow at an annualized rate of ~8.8%, till 2030

R A
May 23, 2022

Roots Analysis has done a detailed study on the Modular Facilities in Pharmaceutical and Biotechnology Market, covering key aspects of the industry and identifying potential future growth opportunities.

 

To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

 

Key Market Insights

  • 30+ companies offer services for the construction of modular facilities; a relatively larger proportion of these firms are headquartered in the US
  • Stakeholders are catering to the needs of various industries, providing services across the globe; in recent years, several small firms / start-ups have been established in this domain
  • Realizing the advantages, many big pharma companies have established modular facilities in the recent past; in addition to capacity expansion, this has allowed them to significantly optimize project cost and timelines
  • The growing interest in this field is evident in the rise in partnership activity in the recent past; in fact, the maximum number of collaborations was reported in 2020
  • Close to 200 industry players claim to offer modular cleanrooms, along with a number of associated services, to the pharmaceutical and biotechnology industries worldwide
  • In addition to shorter construction times, lower financial risks and high internal rate of return are the key advantages offered by modular facilities; experts continue to remain optimistic about proprietary offerings
  • Elaborate profiles of key players that provide a wide range of modular manufacturing solutions to pharmaceutical and biotechnology industries.
  • In the foreseeable future, a variety of lucrative opportunity areas are expected to fuel the adoption of modular solutions within pharma and biotech industry; this is also evident from recent trends observed on google news
  • The projected future opportunity is likely to be distributed across firms that offer different types of modules and construction components to serve multi-purpose market demands
  • Modular manufacturing facility related pharmaceutical operations are anticipated to contribute the major share of revenues, especially those dedicated to emerging biologics
  • In the long run, we expect the market to grow at a CAGR of nearly 10%, with majority of the revenues being generated through the establishment of modular facilities in variable sizes in response to industry demand
  • An in-depth review of emerging trends, including processing technologies with modular facilities, the shift towards smaller, multi-purpose modular facilities, and technological advancements in modular construction processes

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

 

Modular biomanufacturing : Moreover, biopharma industry continues to seek innovative ways of optimizing drug development costs and timelines. Off-site design and modularization demonstrate great potential to provide the industry with the agility to reduce the overall time to market for a particular product

 

 

Table of Contents

 

  1. PREFACE
    1.1. Scope of the Report
    1.2. Research Methodology
    1.3. Key Questions Answered
    1.4. Chapter Outlines

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION
    3.1. Chapter Overview
    3.2. Historical Background
    3.3. The Concept of Modularization
    3.3.1. Types of Modular Constructs
    3.3.2. Modular Construction Process

 

3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction

 

3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects

 

  1. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
    4.1. Chapter Overview
    4.2. Modular Facility Manufacturers: Overall Market Landscape
    4.2.1 Analysis by Year of Establishment
    4.2.2. Analysis by Company Size
    4.2.3. Analysis by Location of Headquarters
    4.2.4. Analysis by Geographical Coverage
    4.2.5. Analysis by Geographical Coverage and GMP Compliance
    4.2.6. Analysis by Type of Industry Served
    4.2.7. Analysis by Geographical Coverage and Type of Industry Served
    4.2.8. Historical and Current Market Landscape Trend Analysis
    4.2.8.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
    4.2.9. Quality Certifications
    4.3. Modular Facility Manufacturers: COVID-19-related Initiatives

 

  1. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
    1. Chapter Overview
    5.2. Modular Cleanroom Providers: Overall Market Landscape
    5.2.1. Analysis by Year of Establishment
    5.2.2. Analysis by Company Size
    5.2.3. Analysis by Location of Headquarters
    5.2.4. Analysis by Type of Industry Served
    5.2.5. Analysis by Type of Modular Cleanroom Offered
    5.2.6. Analysis by Type of Industry Served and Type of Modular Cleanrooms
    5.2.7. Analysis by Type of Cleanroom Component Offered
    5.2.8. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
    5.2.9. Analysis by Type of Industry Served and Type of Cleanroom Component Offered
    5.2.10. Analysis by Location of Headquarters and Type of Industry Served
    5.2.11. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom
    5.2.12. Regulatory Approvals and Certifications

 

Request Sample Pages – https://www.rootsanalysis.com/reports/178/request-sample.html

 

  1. COMPANY PROFILES
    6.1. Chapter Overview
    6.2. Cytiva
    6.2.1. Company Overview
    6.2.2. Modular Facility-related Services
    6.2.3. Modular Projects
    6.2.4. Recent Developments and Future Outlook

 

6.3. G-CON Manufacturing
6.3.1. Company Overview
6.3.2. Modular Facility-related Services
6.3.3. Modular Projects
6.3.4. Recent Developments and Future Outlook

 

6.4. Pharmadule Morimatsu
6.4.1. Company Overview
6.4.2. Modular Facility-related Services
6.4.3. Modular Projects
6.4.4. Recent Developments and Future Outlook

 

6.5. NNE
6.5.1. Company Overview
6.5.2. Modular Facility-related Services
6.5.3. Modular Projects
6.5.4. Recent Developments and Future Outlook

 

6.6. IPM Technologies
6.6.1. Company Overview
6.6.2. Modular Facility-related Services
6.6.3. Modular Projects
6.6.4. Recent Developments and Future Outlook

 

6.7. KeyPlants
6.7.1. Company Overview
6.7.2. Modular Facility-related Services
6.7.3. Modular Projects
6.7.4. Recent Developments and Future Outlook

 

6.8. Germfree Laboratories
6.8.1. Company Overview
6.8.2. Modular Facility-related Services
6.8.3. Modular Projects
6.8.4. Recent Developments and Future Outlook

 

6.9. ModuleCO Pharma
6.9.1. Company Overview
6.9.2. Modular Facility-related Services
6.9.3. Modular Projects
6.9.4. Recent Developments and Future Outlook

 

  1. PARTNERSHIPS AND COLLABORATIONS
    7.1. Chapter Overview
    7.2. Types of Partnership Models

 

7.3. Modular Facility Providers: Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.2.1. Analysis by Year and Type of Partnership
7.3.3. Analysis by Type of Product
7.3.3.1. Analysis by Type of Partnership and Type of Product
7.3.4. Analysis by Type of Modular Facility
7.3.4.1. Analysis by Type of Product and Type of Modular Facility
7.3.5. Most Active Players: Analysis by Number of Partnerships

 

7.3.6. Regional Analysis
7.3.6.1. Analysis by Location of Headquarters of Partner
7.3.6.2. Analysis by Location of Facility
7.3.6.3. Analysis by Type of Partnership and Location of Facility
7.3.6.4. Analysis by Type of Product and Location of Facility
7.3.7. Intercontinental and Intracontinental Partnerships
7.3.7.1. Country-wise Distribution
7.3.7.2. Regional Distribution
7.3.7.3 Analysis by Type of Partnership, Type of Product, Location of Facility and Type of Agreement

 

  1. FEASIBILITY STUDY
    8.1. Chapter Overview
    8.2. Modular Facility Projects Undertaken in the Pharmaceutical / Biotechnology Industry
    8.3. Analysis by Type of Facility
    8.4. Analysis by Facility Area
    8.5. Analysis by Type of Facility and Facility Area
    8.6. Most Active Manufacturers: Analysis by Number of Projects Delivered
    8.7. Most Active Clients: Analysis by Number of Projects Received
    8.8. Analysis by Location of Facility
    8.9. Analysis by Client and Location of Facility
    8.10. Modular versusConventional Construction Methods
    8.11. Return on Investment
    8.12. Case Study: Facility Based on KUBio Platform
    8.12.1. GE Healthcare’s KUBio Platform: Overview
    8.12.2. JHL Biotech’s KUBio Modular Project in China: Overview and Construction Details

 

  1. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
    9.1. Chapter Overview
    9.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry (Top 20 Companies): Historical Data, 2016-2020 (Till December)
    9.2.1. Analysis by Number of Facilities
    9.2.2. Analysis by Type of Facility
    9.2.3. Analysis by Purpose of Facility
    9.2.4. Analysis by Investment
    9.2.5. Analysis by Facility Area
    9.2.6. Analysis by Location of Headquarters

 

Download Free Insights now – https://www.rootsanalysis.com/reports/178/free-insights.html

  1. MARKET FORECAST
    10.1. Chapter Overview
    10.2. Forecast Methodology and Key Assumptions
    10.3. Modular Facilities Market, 2021-2030
    10.4. Modular Facilities Market: Distribution by Type of Modular Construct
    10.4.1. Modular Facilities Market for Hybrid Skid Modular Construct, 2021-2030
    10.4.2. Modular Facilities Market for Plug-and-Play Modular Construct, 2021-2030
    10.4.3. Modular Facilities Market for Skid-Mounted Modular Construct, 2021-2030
    10.4.4. Modular Facilities Market for Truckable Modular Construct, 2021-2030
    10.4.5. Modular Facilities Market for Others, 2021-2030

 

10.5. Modular Facilities Market: Distribution by Type of Construction Component
10.5.1. Modular Facilities Market for Base Building, 2021-2030
10.5.2. Modular Facilities Market for Electrical System, 2021-2030
10.5.3. Modular Facilities Market for Mechanical System, 2021-2030
10.5.4. Modular Facilities Market for Process Equipment, 2021-2030
10.5.5. Modular Facilities Market for Process Piping, 2021-2030
10.5.6. Modular Facilities Market for Process Utilities, 2021-2030
10.5.7. Modular Facilities Market for Other Components, 2021-2030

 

10.6 Modular Facilities Market: Distribution by Purpose of Facility
10.6.1. Modular Facilities Market for Aseptic Filling, 2021-2030
10.6.2. Modular Facilities Market for Manufacturing, 2021-2030
10.6.3. Modular Facilities Market for Research and Development, 2021-2030
10.6.4. Modular Facilities Market for Others, 2021-2030

 

10.7. Modular Facilities Market: Distribution by Facility Area
10.7.1. Modular Facilities Market for Very Small Plants, 2021-2030
10.7.2. Modular Facilities Market for Small Plants, 2021-2030
10.7.3. Modular Facilities Market for Mid-Sized Plants, 2021-2030
10.7.4. Modular Facilities Market for Large Plants, 2021-2030
10.7.5. Modular Facilities Market for Very Large Plants, 2021-2030

 

10.8. Modular Facilities Market: Distribution by Scale of Operation
10.8.1. Modular Facilities Market for Clinical Operations, 2021-2030
10.8.2. Modular Facilities Market for Commercial Operations, 2021-2030

 

10.9. Modular Facilities Market: Distribution by Type of Industry
10.9.1. Modular Facilities Market for Pharmaceutical, 2021-2030
10.9.2. Modular Facilities Market for Biotechnology, 2021-2030

 

10.10. Modular Facilities Market: Distribution by Type of Product
10.10.1. Modular Facilities Market for Biosimilars, 2021-2030
10.10.2. Modular Facilities Market for Cell and Gene Therapies, 2021-2030
10.10.3. Modular Facilities Market for Monoclonal Antibodies, 2021-2030
10.10.4. Modular Facilities Market for Vaccines, 2021-2030
10.10.5. Modular Facilities Market for Other Products, 2021-2030

 

10.11. Modular Facilities Market: Distribution by Key Geographical Regions
10.11.1. Modular Facilities Market for North America, 2021-2030
10.11.2. Modular Facilities Market for Europe, 2021-2030
10.11.3. Modular Facilities Market for Asia, 2021-2030
10.11.4. Modular Facilities Market for Middle East and North Africa, 2021-2030
10.11.5. Modular Facilities Market for Latin America, 2021-2030
10.11.6. Modular Facilities Market for Rest of the World, 2021-2030

 

10.12. Concluding Remarks

 

  1. PREVELANT AND EMERGING INDUSTRY TRENDS
    11.1. Chapter Overview
    11.2. The Pharmaceutical Industry is Rapidly Adopting Smaller Modular Facilities
    11.3. Integration of Single Use Technologies with Modular Facilities Offers Flexibility and Economic Benefits
    11.4. Continuous Processing Technologies Offer Added Advantages to the Modular Approach
    11.5. Modular Facilities are Integrated with Advanced Technology Emphasizing Improved Productivity
    11.6. The Market is Abuzz with Partnership Activity as Service Providers Form Strategic Alliances to Expand their Portfolios

 

  1. FUTURE GROWTH OPPORTUNITIES
    12.1. Chapter Overview
    12.2. The Modular Approach is Popular Amongst Start-Ups and Small Companies
    12.3. In Order to Accelerate Time to Market and Stay Competitive, Several Biosimilar Manufacturers are Expected to Install Modular Facilities
    12.4. Addressing the Niche Requirements, Orphan Indications Offer Additional Opportunities for Modular Facility Manufacturers
    12.5. Emerging Regions are Likely to be Attractive Markets for Stakeholders in the Long Term
    12.6. Expansions of Existing Facilities Using Modular Solutions are Projected to Increase Significantly
    12.7. Several Contract Manufacturing Organizations Have Adopted Modular Solutions

 

  1. CONCLUSION
    13.1. Chapter Overview
    13.2. Key Takeaways

 

  1. EXECUTIVE INSIGHTS
    14.1. Chapter Overview
    14.2. G-CON Manufacturing
    14.2.1. Company Snapshot
    14.2.2. Interview Transcript: Maik Jornitz, Chief Executive Officer

 

14.3. Modwave
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Pär Almhem, President

 

14.4. Environmental Systems Corporation
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Vernon Solomon, President

 

14.5. Exyte
14.5.1. Company Snapshot
14.5.2. Interview Transcript: François Abiven, Executive Vice President, Luca Mussati, Vice President, Technology and Innovation

 

14.6. Avon Modular Construction
14.6.1. Company Snapshot
14.6.2. Interview Transcript: Alan de Zayas, Modular Building Manufacturing and Construction Team

 

14.7. Zeton
14.7.1. Company Snapshot
14.7.2. Interview Transcript: Sulogna Roy, Sales Manager / Project Manager

 

  1. APPENDIX 1:  TABULATED DATA

 

Download Free Insights now – https://www.rootsanalysis.com/reports/178/free-insights.html

 

  1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

You may also be interested in the following titles:

  1. Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
  2. Biopharmaceutical CROs Market, 2021-2030
  3. Continuous Manufacturing Equipment Providers Market, 2021-2030
  4. DNA-Encoded Libraries: Platforms and Services Market
  5. Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

Tags:

Related Articles
Article Estates
Logo
Shopping cart